Pan Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biological Psychiatry top 10%
Papers in
-
- RNA modifications and cancer 5
- Natural product bioactivities and synthesis 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 7
- Co-authors
- Guiyuan Li (11 shared papers)Xiayu Li (10 shared papers)Wei Xiong (7 shared papers)Wenling Zhang (9 shared papers)Qianjin Liao (8 shared papers)Peibo Li (12 shared papers)Zhaoyang Zeng (9 shared papers)Xiaoling Li (6 shared papers)
- Journals
- Journal of Cancer (3 papers)Bioorganic Chemistry (3 papers)Frontiers in Immunology (2 papers)Oncotarget (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Pan Chen
80 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 385
- Biological Psychiatry 37
- Pharmacology 97
- Molecular Biology 683
- Health, Toxicology and Mutagenesis 95
Countries citing papers authored by Pan Chen
This map shows the geographic impact of Pan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan Chen more than expected).
Fields of papers citing papers by Pan Chen
This network shows the impact of papers produced by Pan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan Chen. The network helps show where Pan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 81 | |
| 2 | 2017 | 66 | |
| 3 | 2013 | 65 | |
| 4 | 2022 | 64 | |
| 5 | 2011 | 63 | |
| 6 | 2011 | 59 | |
| 7 | 2015 | 59 | |
| 8 | 2011 | 57 | |
| 9 | 2018 | 50 | |
| 10 | 2016 | 47 | |
| 11 | 2020 | 42 | |
| 12 | 2024 | 41 | |
| 13 | 2017 | 36 | |
| 14 | 2019 | 35 | |
| 15 | 2016 | 32 | |
| 16 | 2019 | 28 | |
| 17 | 2015 | 27 | |
| 18 | 2013 | 27 | |
| 19 | 2019 | 26 | |
| 20 | 2017 | 24 |
About Pan Chen
Pan Chen is a scholar working on Molecular Biology, Cancer Research, Immunology, Plant Science and Physiology, having authored 85 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers), RNA modifications and cancer (5 papers), Immune Response and Inflammation (4 papers), Natural product bioactivities and synthesis (4 papers), Effects and risks of endocrine disrupting chemicals (4 papers), Phytochemistry and Biological Activities (4 papers) and Oral Health Pathology and Treatment (4 papers). The work is most often cited by research in Cancer Research (385 citations), Biological Psychiatry (37 citations), Pharmacology (97 citations), Molecular Biology (683 citations) and Health, Toxicology and Mutagenesis (95 citations). Pan Chen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Guiyuan Li, Xiayu Li, Wei Xiong, Wenling Zhang, Qianjin Liao, Peibo Li, Zhaoyang Zeng, Xiaoling Li, Yonggang Wang and Lichun Xu. Their work appears in journals such as Journal of Cancer, Bioorganic Chemistry, Frontiers in Immunology, Oncotarget and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.